United States · FDA National Drug Code directory
Acamprosate Calcium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68462-435_6560e0ea-e882-4fcd-b523-8c5474d32f91
- Product NDC
- 68462-435
- Form
- TABLET, DELAYED RELEASE
- Composition / generic term
- Acamprosate Calcium
- Labeler
- Glenmark Pharmaceuticals Inc., USA
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20130716
- Source listing expiry
- 20271231
Source-listed ingredients
- ACAMPROSATE CALCIUM — 333 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 10 BLISTER PACK in 1 CARTON (68462-435-11) / 10 TABLET, DELAYED RELEASE in 1 BLISTER PACK · 68462-435-11
- 180 TABLET, DELAYED RELEASE in 1 BOTTLE (68462-435-18) · 68462-435-18
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →